Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2009
View Archived Issues
Phase II data support antitumor activity of tasisulam in platinum-resistant ovarian cancer
Read More
Preliminary results reported from first-in-human study of FP-1039
Read More
AT-13387 shows promising antitumor activity in mouse xenograft models
Read More
Medivir reports results from third quarter of 2009
Read More
Solvay reports results from the third quarter of 2009
Read More
HairDX launches HairDX (RxR) genetic test to assess risk for BPH and response to finasteride
Read More
Asuragen and Life Technologies to develop and distribute diagnostic test for CML
Read More
FDA grants priority review to Actelion's sNDA for miglustat in NP-C
Read More
Afexa Life Sciences starts clinical trial of LIP-01 for reducing blood lipids
Read More
AdCD40L immunotherapy for bladder cancer deemed safe in phase I/IIa trials
Read More
ATI-2042 effective at reducing atrial fibrillation burden in phase II trial
Read More
Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients
Read More
Roche reports results from phase III trial of tocilizumab in sJIA
Read More
Merck & Co. describes CGRP receptor antagonists for the treatment of migraine
Read More
Vitae discloses 11beta-HSD1 inhibitors for the treatment of diabetes
Read More
Novel protease inhibitors in development at Enanta for the treatment of HCV infections
Read More
Seton Hall University presents D1 antagonists as antiepileptic agents
Read More
Sirona Biochem reports results from phase III trial of dapagliflozin in diabetes type 2
Read More
Taisho developing GlyT-1 inhibitors for the treatment of schizophrenia
Read More
Adamas expands phase II AAVID-1 clinical trial of TCAD therapy for influenza
Read More
Myriad reports initial results from ongoing phase IIa trial of Azixa in metastatic melanoma
Read More
Circassia reports results from phase II clinical trial of ToleroMune cat allergy therapy
Read More
European CHMP recommends approval of Merck & Co.'s fertility treatment Elonva
Read More
FDA approves Pfizer's Revatio injection for pulmonary arterial hypertension
Read More
FDA approves Abilify for indication in pediatric patients
Read More
FDA approves Pfizer's Geodon capsules as adjunctive treatment for bipolar disorder
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe